Search
A gift from the estate of renowned fashion designer Geoffrey Beene will enable MSKCC to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center.
A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed 16 students to our annual Summer Undergraduate Research Program.
Paige Arnold, who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner, Jr., for whom the school is named.
A protein on certain immune cells is a promising target for making immunotherapy more effective against breast cancer.
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Degrees were presented and awards were given at the 38th annual ceremony held on May 18.
Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.
Sloan Kettering Institute scientists are using zebrafish to understand human skin cancer that attacks the hands and feet.
An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.